
Evogene Ltd. EVGN
$ 0.74
-0.31%
Annual report 2025
added 04-25-2026
Evogene Ltd. Current Ratio 2011-2026 | EVGN
Annual Current Ratio Evogene Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 | 1.59 | 2.28 | - | - | 4.78 | 6.4 | 7 | 9.44 | 17.1 | 18.5 | 14.9 | 15.1 | 6.03 | 6.66 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.5 | 1.59 | 8.64 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
1.84 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
5.42 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.94 | $ 16.95 | -2.02 % | $ 792 M | ||
|
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.74 | $ 7.45 | -4.85 % | $ 204 M | ||
|
Athira Pharma
ATHA
|
1.43 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
0.796 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
11.2 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | ||
|
AbCellera Biologics
ABCL
|
3.48 | $ 4.1 | -6.82 % | $ 1.22 B | ||
|
Compugen Ltd.
CGEN
|
7.46 | $ 2.82 | -6.93 % | $ 263 M | ||
|
Coherus BioSciences
CHRS
|
1.31 | $ 1.57 | -3.68 % | $ 184 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.58 | -0.94 % | $ 420 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
BioNTech SE
BNTX
|
7.95 | $ 89.3 | -2.92 % | $ 21.6 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
8.41 | - | - | $ 231 M | ||
|
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.38 | -3.15 % | $ 5.56 M | ||
|
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
5.94 | $ 0.74 | 0.4 % | $ 33.8 M | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
Esperion Therapeutics
ESPR
|
0.607 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | ||
|
Eton Pharmaceuticals
ETON
|
1.4 | $ 30.34 | 1.27 % | $ 816 M | ||
|
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
4.16 | $ 49.79 | -2.56 % | $ 13.5 B | ||
|
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
3.26 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 21.68 | 0.51 % | $ 2.76 B | ||
|
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | ||
|
Fortress Biotech
FBIO
|
1.5 | $ 2.4 | 4.13 % | $ 67 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | ||
|
Forte Biosciences
FBRX
|
3.8 | $ 22.78 | -4.92 % | $ 295 M | ||
|
Fennec Pharmaceuticals
FENC
|
2.01 | $ 9.59 | 3.73 % | $ 274 M | ||
|
Aileron Therapeutics
ALRN
|
3.34 | - | 10.36 % | $ 9.8 M |